Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SHS NEW
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
1,895,159
-
Shares change
-
+1,887,659
-
Total reported value, excl. options
-
$40,195,000
-
Value change
-
+$40,035,000
-
Number of buys
-
13
-
Price
-
$21.21
Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q2 2021
14 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q2 2021.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,895,159 shares
.
Largest 10 shareholders include Roumell Asset Management, LLC (563,030 shares), INVESTMENT MANAGEMENT OF VIRGINIA LLC (530,104 shares), VILLERE ST DENIS J & CO LLC (247,250 shares), FRIESS ASSOCIATES LLC (235,092 shares), STATE STREET CORP (176,490 shares), BENJAMIN F. EDWARDS & COMPANY, INC. (64,634 shares), Weil Company, Inc. (30,468 shares), RAYMOND JAMES & ASSOCIATES (20,800 shares), CITADEL ADVISORS LLC (13,034 shares), and ACT Capital Management, LLC (7,500 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.